Triple
T6026339
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Johannes Gutenberg University Mainz |
E134190
|
entity |
| Predicate | hasResearchCenter |
P40
|
FINISHED |
| Object |
Research Center for Immunotherapy
The Research Center for Immunotherapy is a specialized institute at Johannes Gutenberg University Mainz dedicated to advancing understanding and development of immune-based treatments for diseases such as cancer and autoimmune disorders.
|
E564841
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Research Center for Immunotherapy | Statement: [Johannes Gutenberg University Mainz, hasResearchCenter, Research Center for Immunotherapy]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Research Center for Immunotherapy Context triple: [Johannes Gutenberg University Mainz, hasResearchCenter, Research Center for Immunotherapy]
-
A.
Center for Cellular and Molecular Therapeutics
The Center for Cellular and Molecular Therapeutics is a research institute specializing in developing gene and cell-based therapies for pediatric and genetic diseases.
-
B.
Immunology Frontier Research Center
The Immunology Frontier Research Center is a leading research institute at Osaka University dedicated to advanced studies in immunology and related biomedical sciences.
-
C.
Institute of Medical Immunology
The Institute of Medical Immunology is a specialized research and clinical center focused on immune system biology and related diseases within Charité – Universitätsmedizin Berlin.
-
D.
Yale Center for Immuno-Oncology
The Yale Center for Immuno-Oncology is a research and clinical hub at Yale focused on understanding and harnessing the immune system to develop innovative cancer therapies.
-
E.
Center for Cancer Research
The Center for Cancer Research is the intramural research arm of the U.S. National Cancer Institute, conducting basic, translational, and clinical studies to advance cancer prevention, diagnosis, and treatment.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Research Center for Immunotherapy Triple: [Johannes Gutenberg University Mainz, hasResearchCenter, Research Center for Immunotherapy]
Generated description
The Research Center for Immunotherapy is a specialized institute at Johannes Gutenberg University Mainz dedicated to advancing understanding and development of immune-based treatments for diseases such as cancer and autoimmune disorders.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Research Center for Immunotherapy Target entity description: The Research Center for Immunotherapy is a specialized institute at Johannes Gutenberg University Mainz dedicated to advancing understanding and development of immune-based treatments for diseases such as cancer and autoimmune disorders.
-
A.
Center for Cellular and Molecular Therapeutics
The Center for Cellular and Molecular Therapeutics is a research institute specializing in developing gene and cell-based therapies for pediatric and genetic diseases.
-
B.
Immunology Frontier Research Center
The Immunology Frontier Research Center is a leading research institute at Osaka University dedicated to advanced studies in immunology and related biomedical sciences.
-
C.
Institute of Medical Immunology
The Institute of Medical Immunology is a specialized research and clinical center focused on immune system biology and related diseases within Charité – Universitätsmedizin Berlin.
-
D.
Yale Center for Immuno-Oncology
The Yale Center for Immuno-Oncology is a research and clinical hub at Yale focused on understanding and harnessing the immune system to develop innovative cancer therapies.
-
E.
Center for Cancer Research
The Center for Cancer Research is the intramural research arm of the U.S. National Cancer Institute, conducting basic, translational, and clinical studies to advance cancer prevention, diagnosis, and treatment.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69c0087515148190a97475d412563865 |
completed | March 22, 2026, 3:19 p.m. |
| NER | Named-entity recognition | batch_69c0560cdc308190b25ca8ecb42c4e4f |
completed | March 22, 2026, 8:50 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69c11375b4448190ad3087b21ac67329 |
completed | March 23, 2026, 10:18 a.m. |
| NEDg | Description generation | batch_69c11551bec88190be77db3ec96045ad |
completed | March 23, 2026, 10:26 a.m. |
| NED2 | Entity disambiguation (via description) | batch_69c115f88e948190a3ea11b33742779c |
completed | March 23, 2026, 10:29 a.m. |
Created at: March 22, 2026, 4:07 p.m.